KUWAIT CANCER CONTROL CENTER
🇰🇼Kuwait
Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma
Phase 3
Recruiting
- Conditions
- Nasopharyngeal Carcinoma
- Interventions
- Drug: Gemcitabin/cisplatin
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2022-08-17
- Lead Sponsor
- Kuwait Cancer Control Center
- Target Recruit Count
- 120
- Registration Number
- NCT04898374
- Locations
- 🇰🇼
Kuwait Cancer Control Center, Kuwait, Kuwait
EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug
Phase 3
- Conditions
- Drug Use for Unapproved Schedule
- Interventions
- Combination Product: Radiotherapy and chemotherapyDrug: Acyclovir 800 MG
- First Posted Date
- 2018-09-04
- Last Posted Date
- 2018-09-04
- Lead Sponsor
- Kuwait Cancer Control Center
- Target Recruit Count
- 50
- Registration Number
- NCT03656965
- Locations
- 🇰🇼
Kuwait Cancer Control Center, Kuwait, Kuwait
Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer
- First Posted Date
- 2018-05-22
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- Kuwait Cancer Control Center
- Target Recruit Count
- 50
- Registration Number
- NCT03532737
- Locations
- 🇰🇼
Kuwait Cancer Control Center, Kuwait, Kuwait
© Copyright 2025. All Rights Reserved by MedPath